FH inactivating mutations can cause hereditary leiomyomatosis and renal cell cancer (HLRCC), a hereditary cancer syndrome that follows an autosomal dominant inheritance pattern with incomplete penetrance [127]. This evidence concerns the gene FH and hereditary leiomyomatosis and renal cell cancer.